NICE, Nexavar, and why it matters

There has been some strong media and patient outrage in the UK over a decision to not make available Bayer's Nexavar, a drug for terminally-ill liver cancer patients, through the National Health Service.  UK's National Institute for Health and Clinical Excellence - referred to as the NHS' drug rationing body by the UK media - …

Advertisement

Januvia and Galvus : a different take

So here's the thing. While I was waxing eloquent about how Januvia and Galvus were proof that India's patent laws work, and of differential pricing blah,  blah, blah I got a call that spun me around a bit.. A very senior drug safety expert based in New Delhi seemed rather disturbed by the popularity of …